No­vo Nordisk touts ex­pan­sion in Boston, cuts about 100 jobs in two oth­er US cities

No­vo Nordisk is ex­pand­ing its R&D and lab-based ac­tiv­i­ties in Boston while adding jobs — and cut­ting some else­where, too.

The com­pa­ny an­nounced to­day it’s adding more than 200 new jobs, with about 150 of them fo­cused on da­ta sci­ence, bi­ol­o­gy or chem­istry re­search and ri­bonu­cle­ic acid in­ter­fer­ence (RNAi) R&D in Lex­ing­ton, Cam­bridge and Wa­ter­town, MA.

But now that Boston will be the “prin­ci­pal” R&D site in the US, about 20 po­si­tions in In­di­anapo­lis and 80 po­si­tions in Seat­tle will be cut as lab-based work in Seat­tle is moved to oth­er lo­ca­tions glob­al­ly and clos­er to the R&D fa­cil­i­ty in In­di­anapo­lis.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER